Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort

被引:35
作者
Gambier, N
Batt, AM
Marie, B
Pfister, M
Siest, G
Visvikis-Siest, S
机构
[1] Univ Nancy 1, INSERM, Fac Pharm, U525, F-54000 Nancy, France
[2] Ctr Med Prevent, Vandoeuvre Les Nancy, France
关键词
CYP2A6; genetic; polymorphism; nicotine; smoking; French population;
D O I
10.1038/sj.tpj.6500314
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
This study was designed in order to investigate the influence of the genetic polymorphism of CYP2A6 on the amount of smoking. In all, 463 French adults included in the Stanislas cohort were studied and underwent two examinations at 5 years distance (t(0) and t(+5) years). Information on their smoking habits was collected. They were genotyped by RFLP for the CYP2A6*1A, CYP2A6*1B and CYP2A6*4 alleles. CYP2A6*1B and CYP2A6*4 allele frequencies were 32 and 4%, respectively. The subjects carrying the CYP2A6*1B allele oxidize nicotine to cotinine faster than subjects with the CYP2A6*1A allele. The number of cigarettes smoked per day was significantly higher in the CYP2A6*1B/*1B group as compared to the CYP2A6*1A/*1A group (P = 0.01 at t(0); P = 0.001 t(+5) years), with a larger increase in their daily cigarettes consumption over the 5-year period (P = 0.006). No significant difference in the smoking status was observed according to the CYP2A6 genotype. These data suggest thatthe CYP2A6*1B is associated with the number of cigarettes smoked per day.
引用
收藏
页码:271 / 275
页数:5
相关论文
共 32 条
[1]  
Ariyoshi N, 2002, CANCER EPIDEM BIOMAR, V11, P890
[2]   Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C [J].
Ariyoshi, N ;
Takahashi, Y ;
Miyamoto, M ;
Umetsu, Y ;
Daigo, S ;
Tateishi, T ;
Kobayashi, S ;
Mizorogi, Y ;
Loriot, MA ;
Stücker, I ;
Beaune, P ;
Kinoshita, M ;
Kamataki, T .
PHARMACOGENETICS, 2000, 10 (08) :687-693
[3]   The genetic determinants of smoking [J].
Batra, V ;
Patkar, AA ;
Berrettini, WH ;
Weinstein, SP ;
Leone, FT .
CHEST, 2003, 123 (05) :1730-1739
[4]  
Caporaso NE, 2001, CANCER EPIDEM BIOMAR, V10, P261
[5]   A meta-analytic review of the CYP2A6 genotype and smoking behavior [J].
Carter, BL ;
Long, TY ;
Cinciripini, PM .
NICOTINE & TOBACCO RESEARCH, 2004, 6 (02) :221-227
[6]   Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers [J].
Fujieda, M ;
Yamazaki, H ;
Saito, T ;
Kiyotani, K ;
Gyamfi, MA ;
Sakurai, M ;
Dosaka-Akita, H ;
Sawamura, Y ;
Yokota, J ;
Kunitoh, H ;
Kamataki, T .
CARCINOGENESIS, 2004, 25 (12) :2451-2458
[7]   The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit [J].
Gu, DF ;
Hinks, LJ ;
Morton, NE ;
Day, INM .
ANNALS OF HUMAN GENETICS, 2000, 64 :383-390
[8]   The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence [J].
Howard, LA ;
Sellers, EM ;
Tyndale, RF .
PHARMACOGENOMICS, 2002, 3 (02) :185-199
[9]  
Kiyotani Kazuma, 2002, Drug Metab Pharmacokinet, V17, P482, DOI 10.2133/dmpk.17.482
[10]   Nicotine metabolism and CYP2A6 allele frequencies in Koreans [J].
Kwon, JT ;
Nakajima, M ;
Chai, S ;
Yom, YK ;
Kim, HK ;
Yamazaki, H ;
Sohn, DR ;
Yamamoto, T ;
Kuroiwa, Y ;
Yokoi, T .
PHARMACOGENETICS, 2001, 11 (04) :317-323